Martyn Greenacre
Vorsitzender bei CURIS, INC.
Vermögen: 18 949 $ am 30.04.2024
Profil
Martyn D.
Greenacre's current job(s) include Chairman at Curis, Inc., Chairman at Life Mist Technologies, Inc., and Director at Formula Pharmaceuticals, Inc. Mr. Greenacre's former job(s) include President & Chief Executive Officer at Zynaxis, Inc., Chief Executive Officer & Director at Delsys Pharmaceutical Corp., Chairman at Life Mist LLC, Chairman at Beijing Med-Pharm Corp., Director & Chairman-European Operations at Smithkline Beecham Pharmaceuticals (India) Ltd., Chairman at BMP Sunstone Corp., Director at Cephalon, Inc., Director at Creative Biomolecules, Inc., Director at Orchestra Therapeutics, Inc., Director at Acusphere, Inc., Director at NeoStem, Inc., Director at Caladrius Biosciences, Inc., Member-Executive Committee at Applera Corp., and Senior Advisor at Arsenal Capital Management LP.
Mr. Greenacre's education history includes an MBA from Harvard Business School and an undergraduate degree from Harvard College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CURIS, INC.
0,02% | 25.03.2024 | 1 305 ( 0,02% ) | 18 949 $ | 30.04.2024 |
Aktive Positionen von Martyn Greenacre
| Unternehmen | Position | Beginn |
|---|---|---|
| CURIS, INC. | Vorsitzender | 16.05.2017 |
Formula Pharmaceuticals, Inc.
 Formula Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Formula Pharmaceuticals, Inc. develops immunotherapies to treat cancer. It offers chimeric antigen receptor technology. The company was founded by Maurits W. Geerlings and Giorgio Mosconi in 2009 and is headquartered in Berwyn, PA. | Direktor/Vorstandsmitglied | - |
| Life Mist Technologies, Inc. | Vorsitzender | 01.01.2002 |
Ehemalige bekannte Positionen von Martyn Greenacre
| Unternehmen | Position | Ende |
|---|---|---|
| Life Mist LLC | Vorsitzender | 01.12.2016 |
Arsenal Capital Management LP
 Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York. | Private Equity Investor | 31.03.2011 |
| Beijing Med-Pharm Corp. | Vorsitzender | 19.02.2008 |
Orchestra Therapeutics, Inc.
 Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Direktor/Vorstandsmitglied | 01.01.2008 |
Delsys Pharmaceutical Corp.
 Delsys Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Delsys Pharmaceutical Corp. is a pharmaceutical manufacturing company. The private company is based in Princeton, NJ. | Präsident | 01.06.2001 |
Ausbildung von Martyn Greenacre
| Harvard Business School | Masters Business Admin |
| Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CURIS, INC. | Health Technology |
| ACUSPHERE, INC. | Health Technology |
| Private Unternehmen | 15 |
|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
| Life Mist Technologies, Inc. | |
| Life Mist LLC | |
BMP Sunstone Corp.
 BMP Sunstone Corp. Medical/Nursing ServicesHealth Services BMP Sunstone Corp. manufactures, markets and distributes over-the-counter products. The company was founded in November 2003 and is headquartered in Montgomery, PA. | Health Services |
Creative Biomolecules, Inc.
 Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | Health Technology |
Zynaxis, Inc.
 Zynaxis, Inc. Miscellaneous Commercial ServicesCommercial Services Zynaxis, Inc. develops drug delivery systems. The company is based in Malvern, PA. Zynaxis was acquired by Vaxcel, Inc. on December 06, 1996. | Commercial Services |
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Health Technology |
Applera Corp.
 Applera Corp. Medical SpecialtiesHealth Technology Applera Corp. manufactures medical instruments | Health Technology |
Arsenal Capital Management LP
Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York. | Finance |
| Beijing Med-Pharm Corp. | Distribution Services |
Delsys Pharmaceutical Corp.
Delsys Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Delsys Pharmaceutical Corp. is a pharmaceutical manufacturing company. The private company is based in Princeton, NJ. | Health Technology |
Orchestra Therapeutics, Inc.
Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Finance |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
Formula Pharmaceuticals, Inc.
Formula Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Formula Pharmaceuticals, Inc. develops immunotherapies to treat cancer. It offers chimeric antigen receptor technology. The company was founded by Maurits W. Geerlings and Giorgio Mosconi in 2009 and is headquartered in Berwyn, PA. | Technology Services |
| NeoStem, Inc. /Old/ | Transportation |
